Asset Details
Do you wish to reserve the book?
Selected cytokine pathways in rheumatoid arthritis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Selected cytokine pathways in rheumatoid arthritis
Do you wish to request the book?
Selected cytokine pathways in rheumatoid arthritis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Selected cytokine pathways in rheumatoid arthritis
2017
Overview
Rheumatoid arthritis (RA) is a chronic inflammatory disease leading to joint destruction. Cytokines play a key role in its pathogenesis. They contribute to the induction and maintenance of inflammation and thus provide therapeutic targets. Many cytokines are involved in RA, and this review focuses on a few critical ones: tumor necrosis factor (TNF), interleukin (IL)-6, IL-1, IL-17, and GM-CSF. TNF and IL-6 are both well-established targets in RA treatment, and new biologic agents are reaching the market. IL-1 represents a more complex cytokine as results in humans do not reach those in animal models. IL-17 and GM-CSF are cytokines representing new targets either as early treatment or in non-responders to other biologics. The interaction between cytokines and their signaling pathways are the basis for the development of new strategies with small molecules or bispecific antibodies. Clearly, the targeting of cytokines has been a major progress in RA treatment, but many issues remain open. Although remission can be better achieved, reactivation of the disease too often occurs upon treatment discontinuation. Better understanding and targeting of chronicity remains a goal to achieve in the future.
Publisher
Springer Berlin Heidelberg,Springer Nature B.V
Subject
/ Animals
/ Antirheumatic Agents - pharmacology
/ Antirheumatic Agents - therapeutic use
/ Arthritis, Rheumatoid - etiology
/ Arthritis, Rheumatoid - metabolism
/ Arthritis, Rheumatoid - pathology
/ Arthritis, Rheumatoid - therapy
/ Biomedical and Life Sciences
/ Gene Expression Regulation - drug effects
/ Granulocyte-macrophage colony-stimulating factor
/ Humans
/ Inflammation Mediators - metabolism
/ Receptors, Cytokine - metabolism
/ Review
